To see if a drug administered via injection (dupilumab) is safe and effective at reducing eosinophilic inflammation in the stomach of participants with eosinophilic gastritis (EG)/ eosinophilic gastroenteritis (EGE).
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Clinical or Medical
Stomach, Digestion and Gut Health